Back to Trades
Smith Mark Douglas
DirectorCIK 0001756253
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 3
- Active
- 2025–2026
Smith Mark Douglas, Director, has filed 6 SEC reports (2025–2026), spread across 3 companies, totaling $1.1M in disclosed volume. Weighing $0 bought versus $266.7K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Sep 2 | JAZZ Jazz Pharmaceuticals plc | Smith Mark Douglas | Director | Tax withheld | $411.9K |
| Aug 7 | JAZZ Jazz Pharmaceuticals plc | Smith Mark Douglas | Director | Grant | $0 |
| Jun 26 | PHR Phreesia, Inc. | Smith Mark Douglas | Director | Grant | $185.0K |
| Jun 17 | JAZZ Jazz Pharmaceuticals plc | Smith Mark Douglas | Director | Sell | $266.7K |
| May 21 | TDOC Teladoc Health, Inc. | Smith Mark Douglas | Director | Award | $0 |
| Aug 11 | JAZZ Jazz Pharmaceuticals plc | Smith Mark Douglas | Director | Grant | $200.8K |
6 filings